Related Experiment Video
Updated: Jun 27, 2025

08:39
A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
1.7K
Rat Models of Cardiorenal Syndrome and Methods for Functional Assessment
1Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, VIC, Australia. akompa@unimelb.edu.au.
Methods in Molecular Biology (Clifton, N.J.)
|April 27, 2024
Summary
Cardiorenal syndrome (CRS) involves heart and kidney dysfunction. This study details surgical animal models to understand CRS and test new treatments by measuring cardiac and renal function.
Area of Science:
- Cardiology
- Nephrology
- Translational Medicine
Background:
- Cardiorenal syndrome (CRS) is a complex condition characterized by the interplay between heart and kidney dysfunction.
- This interaction leads to adverse clinical outcomes, highlighting the need for better understanding and treatment.
- Current therapeutic strategies for CRS are limited, necessitating further research into its underlying mechanisms.
Purpose of the Study:
- To describe protocols for establishing surgically induced animal models of Cardiorenal Syndrome (CRS).
- To outline methods for assessing cardiac and renal function in these models.
- To provide a framework for evaluating the efficacy of novel therapeutic strategies for CRS.
Main Methods:
- Surgical induction of Cardiorenal Syndrome (CRS) in animal models.
- Measurement of key cardiac function parameters (e.g., ejection fraction, cardiac output).
- Assessment of renal function markers (e.g., creatinine clearance, urine output).
Main Results:
- Established reproducible surgical models of CRS in animals.
- Validated methods for quantifying cardiac and renal dysfunction.
- Demonstrated the utility of these models for evaluating treatment efficacy.
Conclusions:
- Surgically induced animal models are crucial for studying Cardiorenal Syndrome (CRS) pathophysiology.
- These models allow for objective assessment of cardiac and renal function.
- The described protocols facilitate the evaluation of potential therapeutic interventions for CRS.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
Factors Affecting Renal Clearance: Renal Impairment
91
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
91
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K

